Toronto, Ontario, Canada, February 5, 2015 - Ferring Canada, a subsidiary of Ferring Pharmaceuticals group, today announced the availability in Canada of NOCDURNA® (desmopressin orally disintegrating tablets) for adult men and women who awaken up to four times nightly to urinate due to nocturia. Nocturia, a common and bothersome urological condition that equally affects both men and women, is characterized by the repeated need to wake to urinate at night. Nocturia is one of the leading causes of poor sleep quality and affects more than 40 percent of Canadian adults between the ages of 40 and 65 and nearly half of the elderly population.
Newsroom
Thursday, 05 February 2015
